EFFENTORA |
FENTANYL-50 |
DURAGESIC-12 |
DURAGESIC-50 |
FENTANYL-75 |
FENTANYL-100 |
BREAKYL |
N02AB03 |
FENTANYL |
AD 923 |
IONSYS |
DUROGESIC DTRANS |
VICTANYL |
FENTANYL-62 |
MATRIFEN |
DURAGESIC-25 |
R 4263 |
FENTANYL-87 |
IDS-NF-001 |
OPIODUR |
YEMEX |
ORALET |
DUROGESIC |
FENTALIS RESERVOIR |
SUBSYS |
MYLAFENT |
LEPTANAL |
FENCINO |
MEZOLAR MATRIX |
INNOVAR |
DURAGESIC |
DURAGESIC-75 |
FENTANYL-37 |
AD-923 |
FENTORA |
TILOFYL |
SUBLIMAZE |
PECFENT |
FENTANYL-12 |
OSMANIL |
DURAGESIC-100 |
FENTANYL CII |
RECIVIT |
ABSTRAL |
FENTANYL-25 |
OSMACH |
ACTIQ |
DURAGESIC-37 |
FENTANILO |
MCN-JR-4263-49 |
FENTANIL |
N-PHENETHYL-4-(N-PROPIONYLANILINO)PIPERIDINE |
N-(1-PHENETHYL-4-PIPERIDINYL)-N-PHENYLPROPIONAMIDE |
N-(1-PHENETHYL-4-PIPERIDYL)PROPIONANILIDE |
N-(1-PHENETHYL-PIPERIDIN-4-YL)-N-PHENYL-PROPIONAMIDE |
N-PHENYL-N-(1-(2-PHENYLETHYL)-4-PIPERIDINYL)PROPANAMIDE |
1-PHENETHYL-4-(N-PHENYLPROPIONAMIDO)PIPERIDINE |
1-PHENETHYL-4-N-PROPIONYLANILINOPIPERIDINE |
N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLPROPIONAMIDE |
FENTANILA |
R-4263 |
FENTANYLUM |
PHENTANYL |
chembl:CHEMBL596 |
chemidplus:437-38-7 |
rxcui:4337 |
pubchem.compound:3345 |
drugbank:00813 |
Drug Indications | adjuvant to anesthesia |
Drug Indications | analgesic,opioid |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | analgesic |
Year of Approval | approved before 1982 |
Drug Class | adjuvants, anesthesia |
Drug Class | analgesics, opioid |
Drug Categories | agents that produce hypertension |
Drug Categories | agents that reduce seizure threshold |
Drug Categories | antidepressive agents |
Drug Categories | bradycardia-causing agents |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a5 substrates |
Drug Categories | cytochrome p-450 cyp3a7 substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | fentanyl and fentanyl analogues |
Drug Categories | high-risk opioids |
Drug Categories | neuraxial anesthetics |
Drug Categories | opiate agonists |
Drug Categories | opioid agonist |
Drug Categories | opioid anesthetics |
Drug Categories | opioids |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | phenylpiperidine opioids |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin agents |
agonist (activating) |
Trial Name | transmucosal fentanyl,Actiq |
Trial Name | fentanyl transdermal system,Duragesic, Ionsys |
Trial Name | fentanyl sublingual spray |
agonist (activating) |
Direct Interaction? | True |
Endogenous Drug? | False |
Specific Action of the Ligand | Full agonist |
agonist (activating) |
Specific Action of the Ligand | Partial agonist |
Endogenous Drug? | False |
FENTANYL | DrugBank Drug Name |
437-38-7 | CAS Number |
Abstral | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | illicit |
FENTANYL | Primary Drug Name |
Drug Class | analgesics, opioid |
Drug Class | adjuvants, anesthesia |
Year of Approval | approved before 1982 |
Drug Indications | analgesic |
Drug Class | Small Molecule |
FDA Approval | approved |
C494 | NCI drug code |
FENTANYL | GuideToPharmacology Ligand Name |
CHEMBL596 | ChEMBL Drug ID |
D0E1WI | TTD Drug ID |